Related Experiment Video
Updated: Jun 13, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Pediatric non-Hodgkin lymphoma.
Thomas G Gross1, Amanda M Termuhlen
1Department of Pediatrics, The Ohio State University School of Medicine, Division of Hematology/Oncology/BMT, Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA. tgross@chi.osu.edu
Current Hematologic Malignancy Reports
|April 29, 2010
Summary
Pediatric Non-Hodgkin lymphoma (NHL) differs from adult cases. Modern therapies offer over 80% long-term survival for children with this cancer, despite high-grade histology prevalence.
Area of Science:
- Pediatric Oncology
- Hematology
- Cancer Research
Background:
- Non-Hodgkin lymphoma (NHL) represents 7% of childhood cancers in the U.S., with about 1000 new cases annually.
- Pediatric NHL exhibits distinct characteristics compared to adult NHL, including differences in staging, histology, treatment protocols, and patient outcomes.
Purpose of the Study:
- To review current treatment strategies for pediatric Non-Hodgkin lymphoma.
- To highlight key differences between pediatric and adult Non-Hodgkin lymphoma.
Main Methods:
- Literature review of current treatments for pediatric NHL.
- Comparative analysis of pediatric versus adult NHL characteristics.
Main Results:
- Over 90% of pediatric NHL cases present with high-grade histology.
- Modern therapeutic approaches result in long-term event-free survival for more than 80% of pediatric patients.
Conclusions:
- Pediatric Non-Hodgkin lymphoma requires tailored treatment approaches distinct from adult protocols.
- Advances in therapy have significantly improved survival rates for children diagnosed with NHL.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...